Ex-Genta Exec Settles SEC Insider Suit Over Melanoma Drug
A former Genta Inc. executive and two others agreed to pay penalties to resolve allegations of insider trading on confidential information about the now-defunct drugmaker's disappointing clinical tests for the experimental...To view the full article, register now.
Already a subscriber? Click here to view full article